Regulatory Compliance Enforcement Trends, Corporate Compliance Enforcement Among Discussion Topics
(Chicago, IL) – Pharmaceutical and medical device executives will have the opportunity to discuss the latest practices and regulations in remaining compliant at the Life Science Corporate Compliance: Big Data Analysis, Transfer of Value and Global Regulation Conference, May 7-8, 2015 in Chicago. This conference will offer a wide array of discussion topics on both a national and international scale, opportunities for networking, and small group workshops for idea sharing.
Corporate compliance experts from all corners of the life science industry will be on hand to lead presentations, case studies, workshops and panel discussions, and include Sujata T. Dayal of Johnson & Johnson, Erik Egilite of Lundbeck, Michael O’Connor of Boehringer Ingelheim. Topics that will be addressed include tracking relevant data, managing compliance risk through data reporting analysis, value reporting program development and implementation, and more. Delegates will have ample opportunity for Q&A and interactive discussion among peers, as well as take away immediately implementable ideas that will offer a competitive advantage.
Representation from the United States Department of Justice will be leading sessions that explore the latest regulatory compliance enforcement trends in the US, as well as leading an interactive workshop where conference delegates will have the opportunity to address common challenges and gain DOJ-suggested best practices and insight on remaining on the leading edge of compliance regulations.
For more information on the Life Science Corporate Compliance: Big Data Analysis, Transfer of Value and Global Regulation Conference, please email marketing@q1productions.com.
